362 related articles for article (PubMed ID: 27650539)
1. The other face of miR-17-92a cluster, exhibiting tumor suppressor effects in prostate cancer.
Ottman R; Levy J; Grizzle WE; Chakrabarti R
Oncotarget; 2016 Nov; 7(45):73739-73753. PubMed ID: 27650539
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
3. Good or not good: Role of miR-18a in cancer biology.
Kolenda T; Guglas K; Kopczyńska M; Sobocińska J; Teresiak A; Bliźniak R; Lamperska K
Rep Pract Oncol Radiother; 2020; 25(5):808-819. PubMed ID: 32884453
[TBL] [Abstract][Full Text] [Related]
4. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.
Gururajan M; Josson S; Chu GC; Lu CL; Lu YT; Haga CL; Zhau HE; Liu C; Lichterman J; Duan P; Posadas EM; Chung LW
Clin Cancer Res; 2014 Dec; 20(24):6559-69. PubMed ID: 25324143
[TBL] [Abstract][Full Text] [Related]
5. miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer.
Tsuchida A; Ohno S; Wu W; Borjigin N; Fujita K; Aoki T; Ueda S; Takanashi M; Kuroda M
Cancer Sci; 2011 Dec; 102(12):2264-71. PubMed ID: 21883694
[TBL] [Abstract][Full Text] [Related]
6. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways.
Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R
Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995
[TBL] [Abstract][Full Text] [Related]
7. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
[TBL] [Abstract][Full Text] [Related]
8. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
10. miR-92a promotes proliferation and inhibits apoptosis of prostate cancer cells through the PTEN/Akt signaling pathway.
Yanshen Z; Lifen Y; Xilian W; Zhong D; Huihong M
Libyan J Med; 2021 Dec; 16(1):1971837. PubMed ID: 34431444
[TBL] [Abstract][Full Text] [Related]
11. MiR-19b/20a/92a regulates the self-renewal and proliferation of gastric cancer stem cells.
Wu Q; Yang Z; Wang F; Hu S; Yang L; Shi Y; Fan D
J Cell Sci; 2013 Sep; 126(Pt 18):4220-9. PubMed ID: 23868977
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-17-92a cluster promotes autophagy induction in response to celastrol treatment in prostate cancer cells.
Guo J; Mei Y; Li K; Huang X; Yang H
Biochem Biophys Res Commun; 2016 Sep; 478(2):804-10. PubMed ID: 27501757
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
15. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-92a Targets SERTAD3 and Regulates the Growth, Invasion, and Migration of Prostate Cancer Cells via the P53 Pathway.
Zhang S; Yu J; Sun BF; Hou GZ; Yu ZJ; Luo H
Onco Targets Ther; 2020; 13():5495-5514. PubMed ID: 32606766
[TBL] [Abstract][Full Text] [Related]
17. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer.
Majid S; Dar AA; Saini S; Arora S; Shahryari V; Zaman MS; Chang I; Yamamura S; Tanaka Y; Deng G; Dahiya R
Cancer Res; 2012 Dec; 72(24):6435-46. PubMed ID: 23074286
[TBL] [Abstract][Full Text] [Related]
18. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
19. The miR-183 family cluster alters zinc homeostasis in benign prostate cells, organoids and prostate cancer xenografts.
Dambal S; Baumann B; McCray T; Williams L; Richards Z; Deaton R; Prins GS; Nonn L
Sci Rep; 2017 Aug; 7(1):7704. PubMed ID: 28794468
[TBL] [Abstract][Full Text] [Related]
20. Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer.
Bossan A; Ottman R; Andl T; Hasan MF; Mahajan N; Coppola D; Chakrabarti R
BMC Cancer; 2018 Dec; 18(1):1257. PubMed ID: 30558664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
